Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Publication year range
1.
Rev. chil. cir ; 66(1): 22-29, feb. 2014. ilus, tab
Article in Spanish | LILACS | ID: lil-705548

ABSTRACT

El reflujo gastroesofágico (RGE) ha sido asociado como causa de laringitis posterior, sin embargo, la evidencia sobre esto es controversial. El objetivo principal es establecer si los pacientes con síntomas y diagnóstico de laringitis posterior, se correlacionan con la existencia de RGE ácido patológico. Objetivo secundario es el estudio del valor predictivo de cada síntoma laríngeo para reflujo ácido patológico...


Gastroesophageal reflux (GER) is syndicated as a cause of posterior laryngitis. However the evidence for the association is weak. Aim: To determine if the presence of posterior laryngitis is associated with GER.


Subject(s)
Humans , Male , Female , Laryngitis/etiology , Gastroesophageal Reflux/complications , Gastroesophageal Reflux/diagnosis , Cross-Sectional Studies , Hydrogen-Ion Concentration , Manometry , Signs and Symptoms
2.
Drug Target Insights ; 7: 1-8, 2013.
Article in English | MEDLINE | ID: mdl-23400339

ABSTRACT

Patients with functional gastrointestinal disorders express antibodies against gonadotropin-releasing hormone (GnRH) in serum. One common cause of posterior laryngitis (PL) is extra-esophageal reflux, but a functional etiology has also been suggested. The aim of this study was to scrutinize patients with PL with regard to the presence of GnRH antibodies and to examine the association between antibodies and symptoms and reflux. Consecutive PL patients were included after examination. Serum was analyzed for the presence of antibodies using an enzyme-linked immunosorbent assay (ELISA) method and expressed as relative units (RU). Two age- and gender-matched healthy subjects per case served as controls. The prevalence of IgM GnRH antibodies in patients was 35% compared with 28% in controls (P = 0.06), with higher levels in patients (0.8 (0.3-2.2) RU) than in controls (0.2 (0.1-0.6) RU) (P = 0.007). The corresponding IgG antibody prevalences were 43% and 4%, respectively (P = 0.001), with no difference in levels (P = 0.70). There was no association between antibodies and clinical findings.

SELECTION OF CITATIONS
SEARCH DETAIL
...